Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 14 tags : Treatment save search
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Published: 2021-04-14 (Crawled : 00:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 1.09%
C: 0.35%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.27%
H: 0.33%
C: 0.09%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: -0.38%
H: 4.2%
C: 3.09%
treatment europe renal approval cell carcinoma nivolumab
REGENXBIO Announces Dosing of First Patient in Cohort 3 of Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome)
Published: 2021-04-14 (Crawled : 00:00) - biospace.com/
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 0.69%
H: 3.87%
C: 1.26%
treatment trial syndros mps-ih
Omada Health Extends Science of Behavior Change to Musculoskeletal Treatments Through Patented Computer Vision Technology
Published: 2021-04-14 (Crawled : 18:00) - biospace.com/
CI | $348.78 0.78% 0.0% 1.6M
|
Health Services
|
| O: 0.14%
H: 1.92%
C: 1.56%
treatment computer vision patent technology health
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
Published: 2021-04-14 (Crawled : 14:15) - biospace.com/
PRAX | $46.615 -8.2% -8.93% 200K
|
Health Technology
|
| O: 0.0%
H: 0.95%
C: -16.69%
treatment drug designation
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer
Published: 2021-04-14 (Crawled : 14:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.12%
H: 1.85%
C: 0.51%
treatment fda cancer approval license
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction
Published: 2021-04-14 (Crawled : 14:00) - biospace.com/
BWAY | $4.8 -4.95% -5.21% 80K
|
Health Technology
|
| O: -0.44%
H: 2.87%
C: 0.11%
treatment fda depression technology fda clearance
OncoSec Receives CE Mark Certification for its Commercial Electroporation Device GenPulse™ for the Treatment of Solid Tumors
Published: 2021-04-14 (Crawled : 13:00) - biospace.com/
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 0.87%
H: 4.09%
C: 0.22%
treatment solid tumors ce mark device commercialization
BioCryst Announces Approval of Japanese NHI Price Listing of ORLADEYO™ (berotralstat) for Prophylactic Treatment of Hereditary Angioedema
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
BCRX | $4.49 -1.97% -2.0% 3M
|
Health Technology
|
| O: 1.08%
H: 8.68%
C: 4.09%
treatment approval hereditary angioedema
Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
NARI S | $38.63 -0.18% -0.18% 770K
|
Health Technology
|
| O: 0.44%
H: 0.98%
C: -5.51%
treatment partnership
Moleculin Awarded New Rare Pediatric Disease Designation from U.S. FDA for WP1066 for the Treatment of Ependymoma
Published: 2021-04-14 (Crawled : 12:15) - biospace.com/
MBRX | News | $4.59 7.24% 6.75% 50K
|
Health Technology
|
| O: 7.73%
H: 1.79%
C: -5.38%
disease treatment fda rpd wp1066 ependymoma designation rare
Rocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting
Published: 2021-04-14 (Crawled : 12:00) - biospace.com/
RCKT M | $23.44 -1.01% -1.02% 550K
|
Health Technology
|
| O: 0.88%
H: 7.34%
C: 2.57%
treatment positive immunology trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.